	Early physiological phenotypes and survival outcomes in advanced non-small cell lung cancer: a longitudinal study of dynamic muscle loss and functional decline. Front Oncol Yan L, Wu Y, Jiang X, Yao X. PMID: 42666707 [PubMed]
	Early dynamic immune-inflammatory and nutritional recovery signature is associated with durable benefit and early progression in advanced non-small cell lung cancer receiving first-line PD-1/PD-L1 inhibitor-based therapy: a real-world retrospective cohort study. Front Med (Lausanne) Zhan T, Cao H. PMID: 42666280 [PubMed]
	Long-term oncologic outcomes after non-intubated versus intubated video-assisted thoracoscopic surgery for non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Liao YS, Deng YP, Song JL, Yu X, Li Q, Lu B, Chen GY. PMID: 42666271 [PubMed]
	Pneumonitis in Older Patients With Non-squamous Non-small Cell Lung Cancer Treated With Pembrolizumab and Pemetrexed. In Vivo Kogure Y, Hashimoto H, Daga H, Goto Y, Yamada T, Kimura T, Miura S, Yasui H, Yamamoto N, Saka H, Kondo M. PMID: 42665428 [PubMed - indexed for MEDLINE]
	CT-guided Preoperative Localization of Impalpable Pulmonary Nodules: Comparison Between Two Devices. In Vivo Barbiero G, Battistel M, Groff S, Giraudo C, Balestro E, Calabrese F, Mammana M, Dell'amore A. PMID: 42665416 [PubMed - indexed for MEDLINE]
	A GC-MS-based exhaled VOC diagnostic model for distinguishing early-stage lung cancer from controls. Talanta Wang Z, Liu T, Liu B, Zhao H, Huang J, Dong H, Wu W, Zhang G. PMID: 42664649 [PubMed - as supplied by publisher]
	Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial. J Clin Oncol Heymach JV, He J, Harpole D, Mitsudomi T, Taube JM, Gao S, Urban L, Kang JH, Orlandi FJ, Rodriguez-Cid J, Massuti B, Mateos LL, Pasello G, Chu Q, Kolb-Sielecki J, Nakata M, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Horio Y, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Mann H, Fouad TM, Doherty GJ, Reck M. PMID: 42664473 [PubMed - as supplied by publisher]
	Decoding Malignant Lung Ground Glass Opacities: A Radiologic-Pathologic Study From Pure to Semi-Solid Lesions. Thorac Cancer Bonis A, Pagliarini G, Verzeletti V, Cecchinato S, Michielin A, Zanardo S, De Silvestro M, Lione L, Giraudo C, Faccioli E, Cannone G, Mammana M, Rebusso A, Comacchio GM, Schiavon M, Dell'Amore A. PMID: 42663505 [PubMed - indexed for MEDLINE]
	Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). Oncol Rep Zhang Y, Shang Y, Zeng H, Ning R, Zhang X, Ao D, Cai J, Ye Q. PMID: 42663294 [PubMed - indexed for MEDLINE]
	Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable nonâ€‘small cell lung cancer (Review). Oncol Rep Wang L, Feng Y, Liu Q. PMID: 42663281 [PubMed - indexed for MEDLINE]
	Do Generic EGFR-TKIs Perform as Well as Innovators? Real-World Evidence from Gefitinib-Treated EGFR-Mutated NSCLC in Indonesia. Asian Pac J Cancer Prev Nurhayati F, Andalucia R, Thobari JA, Syahruddin E, Anggriani Y. PMID: 42663218 [PubMed - indexed for MEDLINE]
	FGFR2 fusion as the key to targeted therapy - a case report with a diagnostic turning point. Klin Onkol Pe, Drösslerová M, Van, Bocko J. PMID: 42663156 [PubMed - indexed for MEDLINE]
	Potential pitfalls in diagnostic and therapeutic decision-making in pulmonary embolism-related obstructive shock in patients with cancer: a case report. Eur Heart J Case Rep Van den Hoek T, Kayaert P, De Caluwé E, Timmermans P Jr. PMID: 42662840 [PubMed]
	Efficacy and Safety of Durvalumab and Tremelimumab in Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chronic Dis Transl Med Rinaldi I, Yonatan ER, Esterita T. PMID: 42662437 [PubMed - as supplied by publisher]
	Adjuvant chemotherapy with or without targeted therapy for patients with resectable synchronous colon cancer and liver or lung-confined metastases: a nationwide Taiwanese database study. ESMO Gastrointest Oncol Chen PY, Liang YH, Lin BR, Hsu CH, Shao YY. PMID: 42662081 [PubMed]
	Efficacy and safety of B7-H3-targeted antibody-drug conjugates in previously treated small cell lung cancer: a systematic review and meta-analysis with a contextual comparison to topotecan. Front Immunol Wang J, Jiang H, Niu J, Liu L, Wu Y, Shi J, Liu L, Yin S, Feng C, Zhang L, Yang M, Yi Z. PMID: 42661867 [PubMed - indexed for MEDLINE]
	Financial toxicity among patients with lung cancer: a systematic review and meta-analysis. Front Public Health Jiang M, Wang F, Liu Y, Hu Q, Zhao L, Xiong Y, Bian Y. PMID: 42661720 [PubMed - indexed for MEDLINE]
	Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy versus bevacizumab combined with chemotherapy in first-line treatment of driver gene-negative advanced non-squamous non-small cell lung cancer: a single-center retrospective study. Front Oncol Mo W, Li Y, Zhao L, Liu Y, Shu Q, Fei J. PMID: 42661717 [PubMed]
	Comment on "Artificial intelligence construction: a review of the bridge between CT imaging features of lung ground-glass nodules adenocarcinoma and carcinogenic driver genes". J Cancer Res Clin Oncol Abel Jopaul VP, Lingaraj M. PMID: 42661070 [PubMed - indexed for MEDLINE]
	Potentially functional variants of Wnt signaling pathway genes predict risk of primary lung cancer in Chinese Han population. Sci Rep Chen X, Xu Q, Huang L, Hong W, Xu T, Yu L, Zeng Y, He F, Xu Y. PMID: 42660981 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161641

Page 1 of 8083



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy